INS and metabolic dysfunction-associated steatohepatitis: CDN1163 treatment of WD-fed mice restored whole-body indices of glucose tolerance and insulin sensitivity to those of chow-fed mice, which correlated with significant improvements in liver inflammation, fibrosis, and other histological markers of MASH.